Trial Profile
Phase I, Multiple escalating dose study evaluating the safety and tolerability of capecitabine combined with CPT-11 in patients with metastatic breast cancer who had previously treated with anthracyclines and taxanes
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Nov 2015
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Irinotecan (Primary)
- Indications Breast cancer
- Focus Adverse reactions
- 27 Nov 2015 New trial record